Overview
- Trump unveiled TrumpRx.gov at the White House, launching a government‑hosted hub that lists discounts and routes users to manufacturers’ direct‑to‑consumer sites or pharmacy coupons rather than selling drugs itself.
- The site debuted with roughly 40–43 brand‑name medications, including GLP‑1 weight‑loss drugs such as Wegovy, Ozempic and Zepbound, plus diabetes, inhaler, fertility and hepatitis C treatments.
- The White House says about 16 major drugmakers agreed to “most favored nation” pricing in exchange for tariff relief, with initial offers from companies including AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer and more products expected later.
- Advertised examples include Ozempic and Wegovy at about $199–$350 per month depending on dose and Gilead’s Epclusa cut to $2,425 from $24,920, though insured patients may already pay comparable or lower amounts through their coverage.
- Purchases through TrumpRx generally do not count toward insurance deductibles, the platform is reported to be powered by GoodRx, and transparency questions persist as Public Citizen pursues a FOIA lawsuit over the pricing deals’ details and duration.